Imugene raises $18.2 million from investors Clinical stage immuno-oncology company Imugene has closed the Share Purchase Plan component of its capital raising in conjunction with the acquisition of the exclusive licensing rights to the CD19-directed allogeneic cell therapy. The SPP raised a further $18.2 million for the company. Imugene’s Executive Chairman Paul Hopper said: “With…
Boeing Defence sees biggest trades intake Boeing Defence Australia (BDA) has welcomed eight apprentices in the largest single intake to the company’s trades workforce. The apprentices, who have graduated from Aviation Australia’s (AA) 80-day Certificate II in Aircraft Line Maintenance, will join BDA’s F/A-18F Super Hornet and EA-18G Growler maintenance program at RAAF Base Amberley.…
IBISWorld releases new market figures on baby food manufacture Market research firm IBISWorld has published a new Baby Food Manufacturing in Australia report, finding the sector experienced “mixed results” and declined in size by 0.2 over the last five years. The research showed desire for nutrient-added and organic products had supported performance, as had overseas…
XRF Scientific announces record full-year result Analytical laboratory instrument manufacturer XRF Scientific has announced its results for the June 2023 full-year, with sales revenue up 38 per cent to $55.2 million, net profit after tax up 26 per cent to $7.7 million, and the company paying a final fully-franked dividend of 3.3 cents per share.…
